Hereditary Hemorrhagic Telangiectasia (HHT)
At UAMS, our interventional radiologists lead a multidisciplinary team of experts that offer state-of-the-art treatment for hereditary hemorrhagic telangiectasia (HHT).
HHT is a genetic disorder that causes abnormalities of a small percentage of the blood vessels in the body. If these problematic blood vessels rupture, severe bleeding occurs. Abnormalities of small vessels are usually diagnosed as telangiectasias while larger blood vessels are diagnosed as arteriovenous malformations (AVM).
Because HHT has a number of symptoms, diagnosis can be difficult. Even within a family, symptoms vary greatly and include:
- Severe nosebleeds
- Red splotches on the skin, especially the fingertips
Patients with HHT may have blood clots in various areas of the body, including the lungs, which may be very dangerous if left untreated. At academic medical centers like UAMS, our team includes a number of caring and compassionate specialists who can perform procedures that are minimally or noninvasive, allowing patients the opportunity to control this condition and lead a relatively normal life.
In addition to treatment for HHT, UAMS geneticists offer genetic testing to ensure that family members who do not have HHT are not subjected to unnecessary tests or procedures.
Patient Story: Alabama Family Finds Cutting-Edge HHT Treatment at UAMS
Patient Story: UAMS Diagnoses Woman's 16-Year Illness
Patient Story: Patient Finds Special HHT Care at UAMS
Learn more about HHT
To schedule an appointment for testing or treatment for HHT, please contact our Interventional Radiology Clinic.